Table 2

Baseline infusion-related characteristics of study devices

Variable

3-Day Routine Change Group (n = 323),

n (%)

Clinically Indicated Change Group (n = 280),

n (%)


IV cannula gauge

• 22

43 (13%)

46 (16%)

• 20

241 (75%)

201 (72%)

• 18

27 (12%)

30 (11%)

• Other

2 (1%)

3 (1%)

Vein assessment

• Good

143 (44.3%)

107 (38.2%)

• Fair

160 (49.5%)

144 (51.4%)

• Poor

20 (6.2%)

29 (10.4%)

Skin integrity

• Good

138 (43%)

104 (37%)

• Fair

178 (55%)

164 (59%)

• Poor

7 (2%)

12 (4%)

Past history of phlebitis

2 (0.6%)

4 (1.4%)

Insertion site

• Hand

206 (64%)

187 (67%)

• Forearm

59 (18%)

49 (18%)

• Cubital fossa

51 (16%)

38 (14%)

• Other

7 (2%)

6 (2%)

Receiving infusate

241 (75%)

215 (77%)

pH of infusate - Mean (SD)

6.0 (0.5)

6.0 (0.4)

Receiving oral antibiotics

24 (7%)

24 (9%)

Receiving IV antibiotics

236 (73%)

176 (63%)

pH of IV antibiotics - Mean (SD)

6.9 (1.1)

6.9 (1.3)

Receiving other IV meds

190 (59%)

179 (64%)

pH of other IV meds - Mean (SD)

5.6 (2.6)

6.0 (2.8)

Wound drain

50 (16%)

40 (14%)

Urinary catheter

55 (17%)

41 (15%)

Other vascular device

26 (8%)

24 (9%)

Inserted by

• Junior doctor

232 (72%)

207 (74%)

• Registered Nurse

67 (21%)

57 (20%)

• Senior doctor

24 (7%)

16 (6%)

Where inserted

• Ward

216 (67%)

188 (67%)

• Emergency department

74 (23%)

70 (25%)

• Other

33 (10%)

22 (8%)

Current infection (site)

• Respiratory

97 (30%)

49 (18%)

• Urinary

24 (7%)

19 (7%)

• Wound

16 (5%)

15 (5%)

• Other

29 (9%)

37 (13%)

• >1 site

5 (2%)

4 (1%)

N/A (none)

152 (47%)

156 (56%)

Risk of phlebitis (Tagar scale)

• Low

174 (54%)

144 (51%)

• Medium

149 (46%)

136 (49%)

• High

0

0


Rickard et al. BMC Medicine 2010 8:53   doi:10.1186/1741-7015-8-53

Open Data